greeksoup/ stock research

National Healthcare (NHC) FY2023 results: revenue $1.1 billion, up 5.1% on the year

National Healthcare Corp. (NHC) reported revenue of $1.1 billion for fiscal 2023, the year ended 31 December 2023, up 5.1% on the year before. Net income was $67 million, up 197.6%, and diluted earnings per share $4.34. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2024.

Revenue
$1.1 billion
+5.1% on the year
FY2016FY2023
Operating margin
5.0%
2.9% a year earlier
FY2016FY2023
Net income
$67 million
+197.6% on the year
FY2016FY2023
Diluted EPS
$4.34
+199.3% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue1,1421,0861,074+5.1%
Operating income57.531.950.9+80.1%
Operating margin5.0%2.9%4.7%
Interest expense0.30.60.8-42.5%
Pre-tax income88.727.2n/a+225.9%
Income tax23.47.311.0+223.3%
Effective tax rate26.4%26.6%n/a
Net income66.822.4139+197.6%
Net margin5.9%2.1%12.9%
Diluted EPS$4.34$1.45$8.99+199.3%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow1118.762.4+1,172.2%
Capital expenditure27.930.239.4-7.6%
Free cash flow83.3-21.523.0
Free cash flow margin7.3%-2.0%2.1%
Cash from investing-17.6-6.0-65.9
Cash from financing-42.5-47.6-35.3
Depreciation and amortisation42.040.540.7+3.8%
Share-based compensation2.82.62.6+6.5%
Buybacks2.59.90.8-74.9%
Dividends paid35.634.632.0+2.8%
Dividend per share$2.34$2.26$2.11+3.5%
Diluted shares, weighted15m15m15m-0.5%
Shares outstanding at period end15m15m15m-0.0%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity909874903+3.9%
Non-controlling interest1.73.25.5-46.6%
Debt0.00.00.0
Operating lease liabilities63.291.0129-30.6%
Finance lease liabilities0.00.95.8
Other liabilities337306361+10.2%
Total liabilities and equity1,3111,2751,403+2.8%
Fixed assets493507521-2.6%
Goodwill1681681680.0%
Intangible assets7.07.07.00.0%
Securities held for sale or to maturity128143172-10.5%
Cash and equivalents10758.7108+82.5%
Receivables109100.096.1+8.6%
Inventory7.47.18.6+4.2%
Other assets291285323+2.2%
Total assets1,3111,2751,403+2.8%

10-K for the year ended 31 December 2023, filed 16 February 2024: the filing.